Obalon Therapeutics, Inc. (OBLN)

[DS CPA]

Honestly, not a big supporter of the company’s decision to move towards retail weight-loss centers. Makes me curious what the next few quarters look like from a revenue and growth standpoint. My guess is it’ll be very slow. But their balance sheet as of 6/30 is strong and only made stronger by the recent offering.

By my calculation of the O/S the company is trading significantly below net book value, and volume has been low and getting lower. I don’t have a strong belief/opinion in how this will do long-term (although I’d be happy to hear thoughts from any long-term investors), but I think there is strong value at this current price. The technology seems promising and the fact that it doesn’t require surgery or sedation seems like a marketable advantage.

I think the institutional/insider buys at $4 make that an easily achievable short or mid-term target. The fundamentals haven’t changed since then and you can now buy in for less than half of what they paid.

Curious to hear others’ thoughts on the path forward for this company in the current quarter and next. Seems like there is very little active discussion which I guess stands to reason give the slide this has been on.